Latest AI and machine learning research in liver transplantation for healthcare professionals.
PURPOSE OF REVIEW: Despite the introduction of many new immunosuppressive medications, allograft rej...
Hepatitis is a widespread inflammatory condition of the liver, presenting a formidable global health...
With the rising demand for liver transplantation (LT), research on acute rejection (AR) has become i...
BACKGROUND: Liver cancer, particularly hepatocellular carcinoma (HCC), is a major health concern glo...
BACKGROUND AND AIMS: Decompensation of cirrhosis significantly decreases survival, thus, prevention ...
In addition to histological evaluation for nonalcoholic fatty liver disease (NAFLD), a comprehensive...
BACKGROUND: Chronic hepatitis B (CHB) is a common cause of liver cirrhosis (LC), a condition associa...
Viral hepatitis remains a major global health issue, with chronic hepatitis B (HBV) and hepatitis C ...
The classification of Hepatitis C virus (HCV) NS3 inhibitors is essential for identifying potential ...
BACKGROUND: The aim of this study was to develop and internally validate an interpretable machine le...
Breast cancer patients with estrogen receptor-negative (ERneg) status, encompassing triple negative ...
BACKGROUND: Over the years, various models, including both traditional and machine learning models, ...
Interferon (IFN) is a pivotal agent against hepatitis B virus (HBV) in clinic, but there is a lack o...
Hepatitis C virus (HCV) infection represents a significant contributor to chronic liver disease on a...
BACKGROUND & AIMS: Accurate prediction of disease severity and prognosis are challenging in patients...
BACKGROUND: Early recognition of steatosis (fatty liver) and fibrosis in liver health is crucial for...
Early diagnosis at the metabolomic level is crucial for the treatment of liver cirrhosis and hepatoc...
BACKGROUND: Cirrhosis is a leading cause of mortality in patients with chronic liver disease (CLD). ...
Kidney transplantation is the definitive treatment for end-stage renal disease (ESRD), yet challenge...
BACKGROUND: The global prevalence of non-alcoholic fatty liver disease (NAFLD) is approximately 30%,...